FDA Approved: ABIRATERONE — Supplemental Application (Hikma Pharmaceuticals USA Inc.)

View source ↗

Summary

FDA approved Hikma Pharmaceuticals USA Inc.'s supplemental application for Abiraterone acetate under an ANDA.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Castration-resistant Prostate Cancer
• Prostate Cancer

Drugs mentioned

• Abiraterone acetate (Abiraterone acetate)

Snippet

SUPPL AP for ABIRATERONE (ABIRATERONE ACETATE)